Methamnetamine (also known as methylnaphetamine, MNA, MNT, MNAP, PAL-1046, and MY-10) is a triple monoamine releasing agent of the amphetamine and naphthylaminopropane families. It is the N-methyl analog of the non-neurotoxic experimental drug naphthylaminopropane and the naphthalene analog of methamphetamine. It has been sold online as a designer drug between 2015 and 2016.
Pharmacology
Pharmacodynamics Methamnetamine acts as a releasing agent of serotonin, norepinephrine, and dopamine, with EC50 values of 13 nM, 34 nM, and 10 nM, respectively. It is also a lower-potency partial agonist of the serotonin 5-HT2A receptor.
Society and culture
Legal status Methamnetamine is illegal in Japan.
See also 2-MAPB 5-MAPBT BMAPN Naphthylaminopropane Ethylnaphthylaminopropane Naphthylpropylaminopentane HDEP-28 HDMP-28 Naphyrone WF-23
References


